INVESTORS TO CONVERT PREFERRED SHARES AND EXERCISE WARRANTS NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), in an 8-K issued today announced an agreement with investors in certain 2017 underwritten and registered direct offerings, to convert their preferred shares and exercise a substantial portion of their warrants. The benefit to common stockholders... Read more
FRANKLIN LAKES, N.J., March 22, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is updating the instructions for use of certain BD Vacutainer® tubes as part of its quality process to ensure that customers understand the appropriate uses of these products. Since BD became... Read more
New and updated assays increase application areas and improve performance MINNEAPOLIS, March 21, 2018 /PRNewswire/ — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use.... Read more
Collaboration offers potential for PCR-free microRNA biomarker detection with high-specificity and ultra-sensitivity March 20, 2018 06:00 AM Pacific Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration with DestiNA Genomics, a manufacturer of patented reagents for nucleic acid detection.... Read more
INDUSTRY LEADER BRINGS 25 YEARS OF EXPERTISE IN SOFTWARE PRODUCTS AND SERVICES TO HELP HLI SCALE BUSINESS SAN DIEGO, March 19, 2018 /PRNewswire/ — Human Longevity, Inc. (HLI) – the genomics-powered health intelligence company – announced today that Scott Sorensen is joining the leadership team as Chief Technology Officer, reporting to J. Craig Venter, Ph.D., Co-Founder, Chairman and CEO. Sorensen joins... Read more
Three industry leaders join company ranks to drive genomic discovery SAN DIEGO, March 19, 2018 /PRNewswire/ — 9:30 a.m. PT — Luna DNA, the first community owned genomic and medical research database, today announced the addition of three new members to its leadership team. The key hires in the VP of marketing and VP of business strategy and operation... Read more
CMS and Commercial Insurers Extend Coverage of Oncomine Dx Target Test to more than 160 Million U.S. Lives Payors reimburse first NGS, FDA-approved test for non-small cell lung cancer to expedite targeted therapy selection for patients CARLSBAD, Calif., March 19, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced its Oncomine Dx Target Test has been approved for... Read more
Location: Cambridge 16/03/2018 Partnership immediately provides Horizon with deeper access to Chinese diagnostic assay manufacturers and potential OEM agreements as part of stated global leadership strategy Genewell to pursue CFDA approval of Horizon reference standards for broad distribution into Chinese clinical laboratory market Cambridge, UK, and Shenzhen, China, 16 March 2018: Horizon Discovery Group plc... Read more
Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany New site will support complex clinical research and bring more than 200 new jobs to community RHEINFELDEN, Germany, March 16, 2018 /PRNewswire/ — Thermo Fisher Scientific announced today it is expanding its footprint in the European Union and investing $35 million... Read more
HANOI, Vietnam, June 6 /PRNewswire-FirstCall/ -- QIAGEN was featured this week for its efforts to eliminate cervical cancer at the 14th annual Global Summit of Women in Hanoi, Vietnam. CEO Peer Schatz came to this prominent international platform to issue a call to other leaders in business, NGOs and governments to join him and campaign... Read more